HIV Drug Copay Case Spotlights Discriminatory Formulary Issue In Exchange Plans
This article was originally published in The Pink Sheet Daily
Executive Summary
Cigna agrees to cap cost-sharing for some HIV/AIDS drugs at $200 in its exchange plans in Florida as a result of a consent agreement with state regulators. AIDS activists had filed a complaint with HHS alleging Cigna and three other insurers in the state were discriminating against patients with their high copays for HIV/AIDS drugs.